Christoffer Clemmensen
Associate Professor, University of Copenhagen || Co-founder and CSO, Ousia Pharma ApS
- Reposted by Christoffer Clemmensen[Not loaded yet]
- Reposted by Christoffer Clemmensen[Not loaded yet]
- Reposted by Christoffer Clemmensen[Not loaded yet]
- Reposted by Christoffer Clemmensen[Not loaded yet]
- Reposted by Christoffer Clemmensen[Not loaded yet]
- Reposted by Christoffer Clemmensen[Not loaded yet]
- Reposted by Christoffer Clemmensen[Not loaded yet]
- Reposted by Christoffer Clemmensen[Not loaded yet]
- Reposted by Christoffer Clemmensen[Not loaded yet]
- Reposted by Christoffer Clemmensen[Not loaded yet]
- Reposted by Christoffer Clemmensen[Not loaded yet]
- Reposted by Christoffer Clemmensen[Not loaded yet]
- Reposted by Christoffer Clemmensen[Not loaded yet]
- Our latest review, led by @anikavear.bsky.social with Michael Heneka, explores the emerging role of incretin-based therapies in neurodegenerative disease treatment www.nature.com/articles/s42...
- Reposted by Christoffer Clemmensen[Not loaded yet]
- Reposted by Christoffer Clemmensen[Not loaded yet]
- Reposted by Christoffer Clemmensen[Not loaded yet]
- On #WorldObesityDay, we have contributed a SnapShot to a special Issue on Obesity in @cp-cellmetabolism.bsky.social covering brain actions of the current and emerging weight loss drugs. @jonaspetersen.bsky.social @johansenvbi.bsky.social Free access link: authors.elsevier.com/a/1kiaA5WXUlaX…
- Reposted by Christoffer Clemmensen[Not loaded yet]